EQRx Names Carlos Garcia-Echeverria as Chief of Rx Creation

EQRx announced the appointment of Carlos Garcia-Echeverria, Ph.D., as chief of Rx creation. In this role, Dr. Garcia-Echeverria will be responsible for EQRx’ drug creation and early-stage research and development functions to continue to build a pipeline of novel medicines.

EQRx is committed to catalyzing a market-based solution to one of society’s biggest healthcare challenges by developing important new medicines and offering them at lower prices. Through strategic partnerships with stakeholders from across the healthcare system and cutting-edge science and technology, the Company aims to provide high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. EQRx is a purpose-built disruptor at scale, remaking medicine to bend the cost curve in drug pricing.